Bring your burning questions to this closing panel with all the seminar day’s presenters. With all ADC pharmacology topics up for discussion, hear the speakers delve into mechanistic and PD investigation for traditional and novel ADCs to model and characterize the next wave of ADCs heading to the clinic.

Discussion Highlights Include:

• Exploring how pharmacology and mechanistic investigations can strengthen existing ADC knowledge and influence future ADC development
• Debating the therapeutic properties of conditionally active and masked ADCs to assess their ability to differentiate against traditional ADC profiles
• Discussing computational modelling and PK/PD approaches to tackle translational considerations for noncytotoxic payload and novel format ADCs